跳至主要内容
临床试验/CTRI/2013/07/003810
CTRI/2013/07/003810已完成未知

Pharmacodynamic interaction study of Emblica officinalis (CAPROS)with clopidogrel and ecosprin in patients with type II diabetes mellitus.

AYUSH0 个研究点目标入组 10 人开始时间: 待定最近更新:
相关药物

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either gender between 30-70 yrs, on stable dose of anti-diabetic medication (taking Metformin alone in dose between 1000-2500mg per day or in combination with glimiperide maximum 4 mg per day) as prescribed by the physician over past 8 weeks prior to screening visit and having HbA1c between 6.5-8% were enrolled in the study.

排除标准

  • To avoid factors known to affect antiplatelet activity, the following exclusion criteria were applied: severe uncontrolled hyperglycemia, uncontrolled hypertension, cardiac arrhythmia, congestive heart failure, and evidence of hepatic and renal impairment or any other serious chronic disease requiring active treatment. Subjects hypersensitive to the study drugs were also excluded.

研究者

发起方
AYUSH

相似试验